Flotek Q2 revenue jumps on Data Analytics segment growth
FTK•Segment drivers
- Data Analytics growth - Record revenue in Data Analytics segment, which became the largest contributor to gross profit, driven by increased external customer demand and utility infrastructure support agreement
- Chemistry Technologies expansion - Chemistry Technologies revenue reached highest level since 2017, supported by 43% growth in domestic chemistry and 172% growth in international chemistry, particularly in the Middle East
Raised 2026 outlook
- Flotek raises 2026 revenue guidance to $340-$350 mln from $270-$290 mln
- Company lifts 2026 adjusted EBITDA forecast to $47-$51 mln from $36-$41 mln
- Updated 2026 outlook excludes impact from $400 mln Puerto Rico power contract
Key details and analyst coverage
| Metric | Beat/Miss | Actual | Consensus Estimate |
|---|---|---|---|
| Q2 Revenue | Beat | $99.37 mln | $67.72 mln (5 Analysts) |
| Q2 Net Income | $9.95 mln | ||
| Q2 Gross Profit | $23.78 mln |
- The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
- The average consensus recommendation for the specialty chemicals peer group is "buy"
Related News
DigitalBridge Q2 FY26 net income attributable to common stockholders swings to USD 212.68 million; revenue turns positive to USD 508.68 million
DBRG•
International Stem Cell board backs USD 25 million sale of Lifeline Cell Technology to ATCC
ISCO•
